Dr. Ami A Shah from Johns Hopkins discusses the link between Scleroderma and cancer risk, highlighting specific antibody profiles as indicators. The podcast explores genetic alterations, biomarkers, and collaborations in examining this connection. Dr. Shah also shares her journey to becoming a physician-scientist, mentoring others in Scleroderma research through a K24 grant, and emphasizing leadership and collaboration in the Rheumatology Division at Johns Hopkins.